139 results on '"Schefter, T."'
Search Results
2. Phase I Dose Escalation Trial Using 3-Fraction SBRT for Locally Advanced Pancreatic Cancer
3. Multi-Institutional Comparison of SC-TNT and LC-TNT for Rectal Cancer Non-Operative Management
4. Phase II study of neoadjuvant therapy with docetaxel, cisplatin, panitumumab, and radiation therapy followed by surgery in patients with locally advanced adenocarcinoma of the distal esophagus (ACOSOG Z4051)†
5. Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study
6. Compliance and Early Outcomes for Nonoperative Management of Locally Advanced Rectal Cancer at a Single Institution
7. Cardiac Metabolic Changes on FDG-PET after Thoracic Chemoradiation Predict for Dose-response in Esophageal Cancer Patients
8. How should we describe the radiobiologic effect of extracranial stereotactic radiosurgery: Equivalent uniform dose or tumor control probability?
9. Real-Time Kv Target Tracking in Pancreatic SBRT: Characterizing the Clinical and Dosimetric Impact
10. Evaluating PET-Based Functional Imaging Changes in the Heart after Thoracic Chemo-Radiation
11. OC-0301 Real-time kV image guidance in the treatment of pancreatic SBRT: quantifying the purpose and impact
12. Consensus Report From the Miami Liver Proton Therapy Conference
13. Consensus Report From the Miami Liver Proton Therapy Conference
14. Using Machine Learning to Predict Physician-Approved Dose Distributions for Pancreatic SBRT
15. NRG Oncology/RTOG 0529: Long-Term Outcomes of Dose-Painted Intensity Modulated Radiation Therapy, 5-Fluorouracil, and Mitomycin-C in Anal Canal Cancer
16. Rising Rates of Upfront Surgery Followed By Radiation in Locally Advanced Cervical Cancer: What Factors Predict for This Treatment Paradigm?
17. Racial and Income Disparities Predict for Higher Rates of Cut-Through Hysterectomies for Locally Advanced Cervical Cancer
18. Evaluation of Post-esophagectomy Adverse Events in Patients Who Underwent Neoadjuvant Concurrent Chemoradiation
19. Benefits of Real-Time Image Guidance in Dose-Escalated Pancreatic SBRT
20. Impact of Facility Volume on Outcomes in Patients with Squamous Cell Carcinoma of the Anal Canal: Analysis of the National Cancer Data Base
21. To Compress, or to Gate? Abdominal Compression versus Respiratory Gating in Pancreatic Stereotactic Body Radiation Therapy
22. Adjuvant Radiation Therapy Improves Overall Survival in Resected Gastric Adenocarcinoma: A National Cancer Data Base Analysis
23. Contouring of Pancreatic Tumor Volume Is Highly Variable on Interobserver Analysis in the Planning of Stereotactic Body Radiation Therapy
24. TH-CD-207A-04: Optimized Respiratory Gating for Abnormal Breathers in Pancreatic SBRT
25. Patient-specific motion management and adaptive respiratory gating in Pancreatic SBRT
26. Improved Survival With External Beam Radiation Therapy for Patients With Metastatic Esophageal Cancer
27. Disparities in Disease Presentation for Breast, Prostate, Colorectal, and Cervical Cancer According to Insurance Status: Does Insurance Status Predict for Worse Disease Presentation in the Four Screenable Cancers?
28. TH-AB-303-08: Dealing with Erratic Motion: Respiratory Gating Using Internal Surrogates in Pancreatic SBRT
29. Predictors of Radiotherapy-Related GI Toxicity from Anal Cancer DP-IMRT: Secondary Analysis of RTOG 0529
30. Should We Customize PTV Expansions for BMI?: Daily Cone Beam Computerized Tomography to Assess Organ Motion in Postoperative Endometrial and Cervical Cancer Patients
31. Adaptive Motion Mapping in Pancreatic SBRT Patients Using Fourier Transforms
32. Praktische Erfahrungen mit der „LIFT-procedure“ bei der Versorgung der hohen transsphinktären Analfistel
33. PV-0327 - Patient-specific motion management and adaptive respiratory gating in Pancreatic SBRT
34. OC-0505: Patient-specific motion and treatment margins in pancreatic stereotactic body radiation therapy
35. IV Contrast-Enhanced Cone Beam CT to Enhance Image Guidance for Liver SBRT
36. A Phase 2 Study of Neoadjuvant Therapy With Cisplatin, Docetaxel, Panitumumab Plus Radiation Therapy Followed by Surgery in Patients With Locally-Advanced Adenocarcinoma of the Distal Esophagus: Results of ACOSOG Z4051 (Alliance)
37. SU-E-T-412: What Is the Benefit of Fiducial Marker Implantation for Pancreatic SBRT?
38. RTOG 0417: Efficacy of Bevacizumab in Combination With Definitive Radiation Therapy and Cisplatin Chemotherapy in Untreated Patients With Locally Advanced Cervical Carcinoma
39. PO-0778 NORMALIZATION OF SBRT ON LIVER METASTASES: COMPARISON BETWEEN DIFFERENT PRESCRIPTION STRATEGIES
40. Comparison of FDG-PET-based Target Volume Delineation Methods for Patients with Liver Metastases
41. SU-E-T-611: Dosimetric Comparison of Helical to Standard Three Dimensional Conformal Radiation Treatment for Distal Esophageal Cancer
42. MO‐G‐BRC‐04: Normal Liver Tissue Density Dose‐Response in Patients Treated with Stereotactic Body Radiation Therapy for Liver Metastases
43. Phase II multicenter study of erlotinib with radiation therapy (RT) for elderly patients (pts) with esophageal carcinoma (EC): Final report.
44. Clinical Implementation of High Dose MVCT Imaging with Helical Tomotherapy to Improve Image Guidance for SBRT
45. Stereotactic Body Radiation Therapy for Melanoma and Renal Cell Carcinoma: Impact of Single Fraction Equivalent Dose on Local Control
46. RTOG 0417: A Phase II Study of Bevacizumab in Combination with Definitive Radiotherapy and Cisplatin Chemotherapy in Untreated Patients with Locally Advanced Cervical Carcinoma
47. RTOG 0417: A phase II study of bevacizumab in combination with definitive radiotherapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma.
48. Improved Local Control Associated With Dose-Escalated Stereotactic Body Radiation Therapy (SBRT) Indicates Dose-Response Relationship
49. Survival Impact of Neoadjuvant Radiotherapy Prior to Esophagectomy for Patients With Esophageal Cancer: A Surveillance, Epidemiology, and End-Results (SEER) Analysis
50. KRAS mutation analysis in patients (pts) with locally advanced pancreatic cancer (LAPC) treated with gefitinib and chemoradiation therapy (CT-RT) in a phase I trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.